Chip Clark is the founder of Genocea Biosciences. Genocea Biosciences has raised $76M in total funding. Latest round: Series B.
Chip Clark was promoted to President and Chief Executive Officer of Genocea Biosciences in February 2011. Genocea Biosciences is a vaccine discovery and development company focusing on T cell-based vaccines for infectious diseases. Prior to Genocea, Clark co-founded Vanda Pharmaceuticals Inc. in 2004, where he served as chief business officer and helped raise over $220 million. He also worked at Care Capital, LLC, a venture capital firm, and SmithKline Beecham.
Full founder directory · Investor directory · Company funding database · Fundraising library